Search research articles
Contact Us
Filters
Showing results (221-230 of 258) with videos related to
Page
of 26
Sort By:
Diabetes, Obesity & Metabolism
|
December 30, 2020
Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts
Eva Pagano, Stefan R A Konings, Daniela Di Cuonzo, et al.
European Journal of Clinical Investigation
|
January 16, 2007
Nasal nitric oxide in cystic fibrosis with and without humming
V M D Struben, W V Sewbalak, M H Wieringa, et al.
Acta Diabetologica
|
April 21, 2022
The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
Sajad Emamipour, Eva Pagano, Daniela Di Cuonzo, et al.
Oncotarget
|
May 8, 2018
Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study
Rositsa G Koleva-Kolarova, Marcel J W Greuter, Talitha L Feenstra, et al.
The European Respiratory Journal
|
August 2, 2005
A dynamic population model of disease progression in COPD
M Hoogendoorn, M P M H Rutten-van Mölken, R T Hoogenveen, et al.
Pharmacoeconomics
|
June 10, 2023
Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry
Xinyu Li, Rudolf Hoogenveen, Mohamed El Alili, et al.
Plos Medicine
|
February 8, 2008
Lifetime medical costs of obesity: prevention no cure for increasing health expenditure
Pieter H M van Baal, Johan J Polder, G Ardine de Wit, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 16, 2017
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting
Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 27, 2015
Policy evaluation in diabetes prevention and treatment using a population-based macro simulation model: the MICADO model
A A W A van der Heijden, T L Feenstra, R T Hoogenveen, et al.
Diabetologia
|
August 1, 2020
A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspective
Sajad Emamipour, Amber A W A van der Heijden, Giel Nijpels, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 258) with videos related to
Sort By:
Page
of 26
Diabetes, Obesity & Metabolism
|
December 30, 2020
Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts
Eva Pagano, Stefan R A Konings, Daniela Di Cuonzo, et al.
European Journal of Clinical Investigation
|
January 16, 2007
Nasal nitric oxide in cystic fibrosis with and without humming
V M D Struben, W V Sewbalak, M H Wieringa, et al.
Acta Diabetologica
|
April 21, 2022
The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model
Sajad Emamipour, Eva Pagano, Daniela Di Cuonzo, et al.
Oncotarget
|
May 8, 2018
Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study
Rositsa G Koleva-Kolarova, Marcel J W Greuter, Talitha L Feenstra, et al.
The European Respiratory Journal
|
August 2, 2005
A dynamic population model of disease progression in COPD
M Hoogendoorn, M P M H Rutten-van Mölken, R T Hoogenveen, et al.
Pharmacoeconomics
|
June 10, 2023
Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry
Xinyu Li, Rudolf Hoogenveen, Mohamed El Alili, et al.
Plos Medicine
|
February 8, 2008
Lifetime medical costs of obesity: prevention no cure for increasing health expenditure
Pieter H M van Baal, Johan J Polder, G Ardine de Wit, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
March 16, 2017
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting
Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 27, 2015
Policy evaluation in diabetes prevention and treatment using a population-based macro simulation model: the MICADO model
A A W A van der Heijden, T L Feenstra, R T Hoogenveen, et al.
Diabetologia
|
August 1, 2020
A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspective
Sajad Emamipour, Amber A W A van der Heijden, Giel Nijpels, et al.
Page
of 26